Pharmaron Beijing Co., Ltd. (03759)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Shen Rong12-Jun-26INED
Li Shing Chung Gilbert18-Dec-25Emp. Dir.
Li Lihua23-Sep-22INED
Feng Shu11-Dec-20Sup
Yu Jian23-Jul-20INED
Li Jiaqing27-Oct-16NED
Lou Boliang27-Oct-16Ch, CEO, Co-Fdr, ED
Lou Xiaoqiang27-Oct-16Co-Fdr, Pres, ED
Yang Kexin27-Oct-16ChSup
Zhang Lan27-Oct-16Sup
Zheng Bei27-Oct-16Co-Fdr, ED, VP
Li Shing Chung Gilbert01-Jan-15CFO
Yim Issac Lok Kwan25-Apr-2430-Mar-26CoSecMr. Yim has tendered his resignation.
Tsang Benson Kwan Hung28-Nov-1928-Oct-25INEDMr. Tsang Kwan Hung Benson has tendered his resignation as his tenure is approaching six years. The consecutive terms of office of an independent director shall generally not exceed six years.; as per CSRC regulations.
Zhou Qilin23-Sep-2227-Nov-24INEDResignation in compliance with the relevant rules on the part-time management of members of the Chinese Academy of Engineering. Mr. Zhou confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the Stock Exchange or the shareholders of the Company.
Hu Baifeng13-Oct-1725-Apr-24NEDVoluntary resignation due to reallocation of his primary work responsibilities.
Mak Cherie Po Man25-Apr-24CoSecNo reasons provided
Chen Pingjin13-Oct-1721-Jun-23NED
Zhou Hongbin27-Oct-1621-Jun-23NED
Chen Guoqin27-Oct-1623-Sep-22INEDDue to the upcoming expiration of her six-year consecutive term of office as required according to the Rules for Independent Directors of Listed Companies of the China Securities Regulatory Commission
Dai Lixin27-Oct-1623-Sep-22INEDDue to the upcoming expiration of his six-year consecutive term of office as required according to the Rules for Independent Directors of Listed Companies of the China Securities Regulatory Commission
Liu Jun13-Oct-1711-Dec-20Sup
Li Lihua27-Oct-1623-Jul-20INED
Shen Rong27-Oct-1623-Jul-20INED